ReWalk launches clinical study of robotic suit for stroke victims
Courtesy
ReWalk's prototype for a system to help stroke patients walk.
Marlborough medical device manufacturer ReWalk Robotics has launched a clinical study of its robotic suit for the rehabilitation of stroke victims with lower limb disability.
The company’s first clinical study of its Restore soft exo-suit system began last week at the Spaulding Rehabilitation Hospital in Boston, the company announced Tuesday, with a team of researchers from the Boston University College of Health and Rehabilitation Sciences: Sargent College. The location is one of five in which 40 participants will enroll in the study.
The device is the second product line from ReWalk and is designed to be a versatile, cost-effective therapy solution intended to allow therapists to deliver treatment with real-time analytics and adjustability.
According to ReWalk, Restore transmits power to key joins of the legs with cable technologies and is powered with software and mechanics similar to those used in the company’s exoskeleton systems for treatment of spinal cord injuries.
Cables are connected to fabric-based designs attached to a patient's legs and feet, thus the name -- soft suit.
ReWalk hopes to begin the commercial distribution of Restore in the first half of 2018. Commercial approval in the U.S. and Europe is expected once clinical and laboratory testing are completed.
WBJ Web Partners
Most Recent
Most Recent
0 Comments